The FDA cleared Bonalive Maxillofacial, a synthetic bone grafting material from Bonalive , Ltd. (Turku, FI), under 510(k) K253883 on May 14, 2026.
- Source
- U.S. FDA 510(k) database
accessdata.fda.gov - Published
- May 14, 2026
- Type
- FDA
- Checked
- October 2, 2026
